Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study

Table 2 Summary of Characteristics by Race (Total 225 patients)

Factor	Group	Total	White	Black	API	Hispanic	P value
n (%)		225	124 (55.1)	27 (12.0)	22 (9.8)	52 (23.1)
Median age (IQR)		27 (19-56)	27.0 (19-54.5)	32.0 (21-55)	52.0 (27-70)	23.0 (17-53.5)	0.04
Age groups (%)	≤ 19	62 (27.5)	34 (54.8)	6 (9.7)	3 (4.8)	19 (30.7)	0.07
	20-59	114 (50.7)	67 (58.8)	16 (14.0)	9 (7.9)	22 (19.3)
	≥ 60	49 (21.8)	23 (46.9)	5 (10.2)	10 (20.4)	11 (22.5)
Male (%)		141 (62.7)	75 (53.2)	18 (12.8)	14 (9.9)	34 (24.1)	0.89
Household income (%)	< $55000	55 (24.4)	34 (61.8)	10 (18.2)	1 (1.8)	10 (18.2)	0.02
	$55000-70000	88 (39.1)	42 (47.7)	6 (6.8)	12 (13.6)	28 (31.8)
	> $70000	82 (36.4)	48 (58.5)	11 (13.4)	9 (11.0)	14 (17.1)
Living settings (%)	Population > 1 million	144 (61.0)	68 (47.2)	21 (14.6)	18 (12.5)	37 (25.7)	0.01
	Other	81 (36.0)	56 (69.1)	6 (7.4)	4 (4.9)	15 (18.5)
Stages (%)	I	65 (28.9)	38 (58.5)	7 (10.8)	7 (10.8)	13 (20.0)	0.71
	II	18 (8.0)	11 (61.1)	2 (11.1)	2 (11.1)	3 (16.7)
	III	61 (27.1)	30 (49.2)	7 (11.5)	3 (4.9)	21 (34.4)
	IV	61 (27.1)	34 (55.7)	7 (11.5)	8 (13.1)	12 (19.7)
	Unknown	20 (8.9)	11 (55.0)	4 (20.0)	2 (10.0)	3 (15.0)
Lymph Node status (%)	N0	143 (63.6)	74 (51.8)	16 (11.2)	17 (11.9)	36 (25.2)	0.11
	N1	60 (26.7)	38 (63.3)	5 (8.3)	3 (5.0)	14 (23.3)
	Nx	22 (9.78)	12 (54.6)	6 (27.3)	2 (9.1)	2 (9.1)
Metastasis status (%)	M0	154 (68.4)	85 (55.2)	18 (11.7)	12 (7.8)	39 (25.3)	0.63
	M1	61 (27.1)	34 (55.7)	7 (11.5)	8 (13.1)	12 (19.7)
	Mx	10 (4.4)	5 (50.0)	2 (20.0)	2 (20.0)	1 (10.0)
Surgery (%)	Wedge/segmental resection	39 (17.8)	28 (71.8)	2 (5.1)	3 (7.7)	6 (15.4)	0.28
	Lobectomy	42 (19.2)	25 (59.5)	6 (14.3)	3 (7.1)	8 (19.1)
	Extended lobectomy	11 (5.0)	5 (45.5)	0 (0)	1 (9.1)	5 (45.5)
	Transplant	19 (8.7)	12 (63.2)	2 (10.5)	1 (5.3)	4 (21.1)
	None	108 (49.3)	49 (45.4)	17 (15.7)	13 (12.0)	29 (26.9)